European Union - English - EMA (European Medicines Agency)

alnylam netherlands b.v. - lumasiran sodium - hyperoxaluria, primary - other alimentary tract and metabolism products, - treatment of primary hyperoxaluria type 1 (ph1) in all age groups.

Israel - English - Ministry of Health

medison pharma ltd - lumasiran as sodium - solution for injection - lumasiran as sodium 189 mg / 1 ml - lumasiran - oxlumo is indicated for the treatment of primary hyperoxaluria type 1 (ph1) in all age groups.

Canada - English - Health Canada

alnylam netherlands b.v. - lumasiran (lumasiran sodium) - solution - 94.5mg - lumasiran (lumasiran sodium) 94.5mg